vs
Coursera, Inc.（COUR）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是Coursera, Inc.的1.1倍（$207.3M vs $196.9M），Coursera, Inc.净利率更高（-13.6% vs -62.0%，领先48.4%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 9.9%），Coursera, Inc.自由现金流更多（$5.4M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 7.9%）
Coursera Inc.是美国营利性在线教育平台，由斯坦福大学计算机科学教授吴恩达与达芙妮·科勒于2012年创立。创立初期它作为全球大型开放式网络课程平台运营，目前和全球多所大学及各类机构合作，提供涵盖多个学科领域的在线课程、证书与学位项目。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
COUR vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $196.9M | $207.3M |
| 净利润 | $-26.8M | $-128.6M |
| 毛利率 | 54.2% | — |
| 营业利润率 | -16.4% | -54.7% |
| 净利率 | -13.6% | -62.0% |
| 营收同比 | 9.9% | 25.9% |
| 净利润同比 | -24.1% | 3.5% |
| 每股收益（稀释后） | $-0.16 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $196.9M | $207.3M | ||
| Q3 25 | $194.2M | $159.9M | ||
| Q2 25 | $187.1M | $166.5M | ||
| Q1 25 | $179.3M | $139.3M | ||
| Q4 24 | $179.2M | $164.6M | ||
| Q3 24 | $176.1M | $139.5M | ||
| Q2 24 | $170.3M | $147.0M | ||
| Q1 24 | $169.1M | $108.8M |
| Q4 25 | $-26.8M | $-128.6M | ||
| Q3 25 | $-8.6M | $-180.4M | ||
| Q2 25 | $-7.8M | $-115.0M | ||
| Q1 25 | $-7.8M | $-151.1M | ||
| Q4 24 | $-21.6M | $-133.2M | ||
| Q3 24 | $-13.7M | $-133.5M | ||
| Q2 24 | $-22.9M | $-131.6M | ||
| Q1 24 | $-21.3M | $-170.7M |
| Q4 25 | 54.2% | — | ||
| Q3 25 | 54.6% | — | ||
| Q2 25 | 54.9% | — | ||
| Q1 25 | 54.6% | — | ||
| Q4 24 | 53.3% | — | ||
| Q3 24 | 54.6% | — | ||
| Q2 24 | 53.0% | — | ||
| Q1 24 | 52.9% | — |
| Q4 25 | -16.4% | -54.7% | ||
| Q3 25 | -8.0% | -106.9% | ||
| Q2 25 | -8.1% | -64.8% | ||
| Q1 25 | -8.0% | -102.6% | ||
| Q4 24 | -17.0% | -74.3% | ||
| Q3 24 | -12.3% | -94.6% | ||
| Q2 24 | -18.3% | -79.1% | ||
| Q1 24 | -17.6% | -151.9% |
| Q4 25 | -13.6% | -62.0% | ||
| Q3 25 | -4.4% | -112.8% | ||
| Q2 25 | -4.2% | -69.0% | ||
| Q1 25 | -4.4% | -108.5% | ||
| Q4 24 | -12.1% | -80.9% | ||
| Q3 24 | -7.8% | -95.7% | ||
| Q2 24 | -13.4% | -89.5% | ||
| Q1 24 | -12.6% | -156.8% |
| Q4 25 | $-0.16 | $-1.28 | ||
| Q3 25 | $-0.05 | $-1.81 | ||
| Q2 25 | $-0.05 | $-1.17 | ||
| Q1 25 | $-0.05 | $-1.57 | ||
| Q4 24 | $-0.13 | $-1.34 | ||
| Q3 24 | $-0.09 | $-1.40 | ||
| Q2 24 | $-0.15 | $-1.52 | ||
| Q1 24 | $-0.14 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $792.6M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $635.7M | $-80.0M |
| 总资产 | $1.0B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $792.6M | $421.0M | ||
| Q3 25 | $797.7M | $202.5M | ||
| Q2 25 | $775.1M | $176.3M | ||
| Q1 25 | $748.0M | $127.1M | ||
| Q4 24 | $726.1M | $174.0M | ||
| Q3 24 | $719.4M | $150.6M | ||
| Q2 24 | $708.8M | $480.7M | ||
| Q1 24 | $725.4M | $112.3M |
| Q4 25 | $635.7M | $-80.0M | ||
| Q3 25 | $639.5M | $9.2M | ||
| Q2 25 | $627.0M | $151.3M | ||
| Q1 25 | $610.5M | $144.2M | ||
| Q4 24 | $597.4M | $255.0M | ||
| Q3 24 | $593.3M | $346.8M | ||
| Q2 24 | $585.2M | $432.4M | ||
| Q1 24 | $609.1M | $140.3M |
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $995.3M | $1.2B | ||
| Q2 25 | $979.9M | $1.3B | ||
| Q1 25 | $951.2M | $1.3B | ||
| Q4 24 | $930.3M | $1.5B | ||
| Q3 24 | $914.1M | $1.5B | ||
| Q2 24 | $904.4M | $1.6B | ||
| Q1 24 | $916.3M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.8M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $5.4M | $-100.8M |
| 自由现金流率自由现金流/营收 | 2.7% | -48.6% |
| 资本支出强度资本支出/营收 | 0.2% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $107.2M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $5.8M | $-99.8M | ||
| Q3 25 | $33.9M | $-91.4M | ||
| Q2 25 | $35.5M | $-108.3M | ||
| Q1 25 | $33.5M | $-166.5M | ||
| Q4 24 | $19.2M | $-79.3M | ||
| Q3 24 | $27.9M | $-67.0M | ||
| Q2 24 | $23.8M | $-77.0M | ||
| Q1 24 | $24.5M | $-190.7M |
| Q4 25 | $5.4M | $-100.8M | ||
| Q3 25 | $33.7M | $-92.7M | ||
| Q2 25 | $35.1M | $-110.7M | ||
| Q1 25 | $33.0M | $-167.8M | ||
| Q4 24 | $18.1M | $-79.5M | ||
| Q3 24 | $27.7M | $-68.6M | ||
| Q2 24 | $23.6M | $-79.0M | ||
| Q1 24 | $24.4M | $-193.9M |
| Q4 25 | 2.7% | -48.6% | ||
| Q3 25 | 17.4% | -58.0% | ||
| Q2 25 | 18.8% | -66.5% | ||
| Q1 25 | 18.4% | -120.5% | ||
| Q4 24 | 10.1% | -48.3% | ||
| Q3 24 | 15.7% | -49.2% | ||
| Q2 24 | 13.9% | -53.7% | ||
| Q1 24 | 14.4% | -178.2% |
| Q4 25 | 0.2% | 0.5% | ||
| Q3 25 | 0.1% | 0.8% | ||
| Q2 25 | 0.2% | 1.5% | ||
| Q1 25 | 0.3% | 1.0% | ||
| Q4 24 | 0.6% | 0.1% | ||
| Q3 24 | 0.1% | 1.2% | ||
| Q2 24 | 0.1% | 1.4% | ||
| Q1 24 | 0.1% | 3.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COUR
| Consumer Segment | $131.5M | 67% |
| Enterprise Segment | $65.4M | 33% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
